Consistent bone mineral density gains with intravenous ibandronate injections: Results from the DIVA study.

被引：0
|
作者：
Emkey, R
Halse, J
Kruse, HP
Hughes, C
Ward, P
Masanauskaite, D
Recker, RR
机构：
[1] Radiant Res, Wyomissing, PA USA
[2] Osteoporoseklin, Oslo, Norway
[3] Univ Hamburg, Klinikum Eppendorf, Hamburg, Germany
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Creighton Univ, Omaha, NE 68178 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [1] Bone safety of intermittent intravenous ibandronate injections: Bone histomorphometry from the DIVA study.
    Recker, R.
    Czerwinski, E.
    Felsenberg, D.
    Hughes, C.
    Bonvoisin, B.
    Masanauskaite, D.
    Ste-Marie, L. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S15 - S15
  • [2] Pronounced increases in bone mineral density with intermittent intravenous ibandronate injections: 2-year results from DIVA
    Delmas, P. D.
    Eisman, J. A.
    Stepan, J.
    Hughes, C.
    Mairon, N.
    Masanauskaite, D.
    Felsenberg, D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S12 - S12
  • [3] The DIVA study: Substantial hip bone mineral density improvements with intermittent intravenous ibandronate injections.
    Lewiecki, E.
    Adami, S.
    Bianchi, G.
    Sambrook, P.
    Hughes, C.
    Mairon, N.
    Jonkanski, I.
    Bolognese, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S70 - S70
  • [4] Favorable renal tolerability with intermittent intravenous ibandronate injections: The DIVA study.
    Civitelli, R.
    Stepan, J.
    Leigh, C.
    Ward, P.
    Burdeska, A.
    Reid, D. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S414 - S414
  • [5] Intermittent intravenous ibandronate injections are associated with newly formed bone of normal quality: The DIVA study.
    Ste-Marie, Louis-Georges
    Langdahl, Bente
    Dieter-Felsenberg
    Czerwinski, Edward
    Hughes, Claire
    Bonvoisin, Bernard
    Masanauskaite, Daiva
    Recker, Robert R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S583 - S583
  • [6] Bone resorption is effectively normalised by intermittent intravenous ibandronate injections: The DIVA study
    Reid, D. M.
    Sambrook, P. N.
    Garnero, P.
    Hughes, C.
    Masanauskaite, D.
    Stakkestad, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S70 - S71
  • [7] Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2-Year Results from the DIVA Study
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (03): : 159 - +
  • [8] Two-year efficacy and tolerability of intermittent intravenous ibandronate injections in postmenopausal osteoporosis: the DIVA study.
    Emkey, R
    Zaidi, V
    Lewiecki, EM
    Burdeska, A
    Mairon, N
    Rowell, L
    Eisman, JA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4060 - 4060
  • [9] EFFECT OF MONTHLY INTRAVENOUS IBANDRONATE INJECTIONS ON BONE MINERAL DENSITY IN JAPANESE OSTEOPOROSIS PATIENTS
    Ikeda, S.
    Tanaka, H.
    Murai, T.
    Tamaru, M.
    Matsumoto, H.
    Okimoto, N.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S379 - S380
  • [10] Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
    Eisman, John A.
    Civitelli, Roberto
    Adaml, Silvano
    Czerwinski, Edward
    Recknor, Chris
    Prince, Richard
    Reginster, Jean-Yves
    Zaidi, Mone
    Felsenberg, Dieter
    Hughes, Claire
    Mairon, Nicole
    Masanauskaite, Daiva
    Reid, David M.
    Delmas, Pierre D.
    Recker, Robert R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 488 - 497
12345